Relapsed Diffuse Large B-cell Lymphoma (DLBCL)
3 clinical trials · Condition
◉ Watch Relapsed Diffuse Large B-cell Lymphoma (DLBCL)
| Record | Firm | Date |
|---|---|---|
| Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL) (NCT02570542) | Memorial Sloan Kettering Cancer Center | 2015-10-01 |
Track Relapsed Diffuse Large B-cell Lymphoma (DLBCL) automatically
Every clearance here is in the API, with alerts when new ones post.